MOH Quote, Financials, Valuation and Earnings

Centene Corp. has a net margin of -1.41% compared to Molina Healthcare, Inc.'s net margin of -2.21%. Molina Healthcare, Inc.'s return on equity of 10.89% beat Centene Corp.'s return on equity of -27.11%.

Molina Healthcare, Inc. has a consensus price target of $155.69, signalling upside risk potential of 3.76%. On the other hand Centene Corp. has an analysts' consensus of $44.76 which suggests that it could fall by -0.5%. Given that Molina Healthcare, Inc. has higher upside potential than Centene Corp., analysts believe Molina Healthcare, Inc. is more attractive than Centene Corp..

Molina Healthcare, Inc. has a beta of 0.518, which suggesting that the stock is 48.232% less volatile than S&P 500. In comparison Centene Corp. has a beta of 0.480, suggesting its less volatile than the S&P 500 by 51.962%.

Molina Healthcare, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Centene Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Molina Healthcare, Inc. pays -- of its earnings as a dividend. Centene Corp. pays out -- of its earnings as a dividend.

Molina Healthcare, Inc. quarterly revenues are $11.4B, which are smaller than Centene Corp. quarterly revenues of $49.7B. Molina Healthcare, Inc.'s net income of -$160M is higher than Centene Corp.'s net income of -$1.1B. Notably, Molina Healthcare, Inc.'s price-to-earnings ratio is 17.54x while Centene Corp.'s PE ratio is 8.66x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Molina Healthcare, Inc. is 0.17x versus 0.11x for Centene Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Elevance Health, Inc. has a net margin of -1.41% compared to Molina Healthcare, Inc.'s net margin of 1.1%. Molina Healthcare, Inc.'s return on equity of 10.89% beat Elevance Health, Inc.'s return on equity of 13.1%.

Molina Healthcare, Inc. has a consensus price target of $155.69, signalling upside risk potential of 3.76%. On the other hand Elevance Health, Inc. has an analysts' consensus of $387.85 which suggests that it could grow by 33.08%. Given that Elevance Health, Inc. has higher upside potential than Molina Healthcare, Inc., analysts believe Elevance Health, Inc. is more attractive than Molina Healthcare, Inc..

Molina Healthcare, Inc. has a beta of 0.518, which suggesting that the stock is 48.232% less volatile than S&P 500. In comparison Elevance Health, Inc. has a beta of 0.511, suggesting its less volatile than the S&P 500 by 48.861%.

Molina Healthcare, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Elevance Health, Inc. offers a yield of 2.35% to investors and pays a quarterly dividend of $1.71 per share. Molina Healthcare, Inc. pays -- of its earnings as a dividend. Elevance Health, Inc. pays out 27.13% of its earnings as a dividend. Elevance Health, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Molina Healthcare, Inc. quarterly revenues are $11.4B, which are smaller than Elevance Health, Inc. quarterly revenues of $49.7B. Molina Healthcare, Inc.'s net income of -$160M is lower than Elevance Health, Inc.'s net income of $546M. Notably, Molina Healthcare, Inc.'s price-to-earnings ratio is 17.54x while Elevance Health, Inc.'s PE ratio is 11.61x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Molina Healthcare, Inc. is 0.17x versus 0.33x for Elevance Health, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Oscar Health, Inc. has a net margin of -1.41% compared to Molina Healthcare, Inc.'s net margin of -12.56%. Molina Healthcare, Inc.'s return on equity of 10.89% beat Oscar Health, Inc.'s return on equity of -40.11%.

Molina Healthcare, Inc. has a consensus price target of $155.69, signalling upside risk potential of 3.76%. On the other hand Oscar Health, Inc. has an analysts' consensus of $15.40 which suggests that it could grow by 2.33%. Given that Molina Healthcare, Inc. has higher upside potential than Oscar Health, Inc., analysts believe Molina Healthcare, Inc. is more attractive than Oscar Health, Inc..

Molina Healthcare, Inc. has a beta of 0.518, which suggesting that the stock is 48.232% less volatile than S&P 500. In comparison Oscar Health, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Molina Healthcare, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Oscar Health, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Molina Healthcare, Inc. pays -- of its earnings as a dividend. Oscar Health, Inc. pays out -- of its earnings as a dividend.

Molina Healthcare, Inc. quarterly revenues are $11.4B, which are larger than Oscar Health, Inc. quarterly revenues of $2.8B. Molina Healthcare, Inc.'s net income of -$160M is higher than Oscar Health, Inc.'s net income of -$352.4M. Notably, Molina Healthcare, Inc.'s price-to-earnings ratio is 17.54x while Oscar Health, Inc.'s PE ratio is 51.21x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Molina Healthcare, Inc. is 0.17x versus 0.36x for Oscar Health, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

UnitedHealth Group, Inc. has a net margin of -1.41% compared to Molina Healthcare, Inc.'s net margin of 0.19%. Molina Healthcare, Inc.'s return on equity of 10.89% beat UnitedHealth Group, Inc.'s return on equity of 12.31%.

Molina Healthcare, Inc. has a consensus price target of $155.69, signalling upside risk potential of 3.76%. On the other hand UnitedHealth Group, Inc. has an analysts' consensus of $364.63 which suggests that it could grow by 26.08%. Given that UnitedHealth Group, Inc. has higher upside potential than Molina Healthcare, Inc., analysts believe UnitedHealth Group, Inc. is more attractive than Molina Healthcare, Inc..

Molina Healthcare, Inc. has a beta of 0.518, which suggesting that the stock is 48.232% less volatile than S&P 500. In comparison UnitedHealth Group, Inc. has a beta of 0.406, suggesting its less volatile than the S&P 500 by 59.394%.

Molina Healthcare, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. UnitedHealth Group, Inc. offers a yield of 3.02% to investors and pays a quarterly dividend of $2.21 per share. Molina Healthcare, Inc. pays -- of its earnings as a dividend. UnitedHealth Group, Inc. pays out 65.97% of its earnings as a dividend. UnitedHealth Group, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Molina Healthcare, Inc. quarterly revenues are $11.4B, which are smaller than UnitedHealth Group, Inc. quarterly revenues of $113.2B. Molina Healthcare, Inc.'s net income of -$160M is lower than UnitedHealth Group, Inc.'s net income of $218M. Notably, Molina Healthcare, Inc.'s price-to-earnings ratio is 17.54x while UnitedHealth Group, Inc.'s PE ratio is 21.92x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Molina Healthcare, Inc. is 0.17x versus 0.59x for UnitedHealth Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.